Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares
Lloyd Price
FEBRUARY 18, 2024
Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. 2005: Liraglutide, another GLP-1 RA, joins the scene, offering longer-lasting action.
Let's personalize your content